13.36
+0.35
+(2.69%)
As of 10:57:07 AM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
3,558.51
2,685.66
2,346.12
Total Liabilities Net Minority Interest
3,942.83
1,313.13
1,149.03
Total Equity Gross Minority Interest
-384.32
1,372.53
1,197.09
Total Capitalization
-384.32
1,372.53
1,197.09
Common Stock Equity
-384.32
1,372.53
1,197.09
Capital Lease Obligations
1,611.82
608.77
720.63
Net Tangible Assets
-384.32
1,372.53
1,197.09
Working Capital
-1,201.68
834.88
645.56
Invested Capital
-384.32
1,372.53
1,197.09
Tangible Book Value
-384.32
1,372.53
1,197.09
Total Debt
1,611.82
608.77
720.63
Share Issued
8,127.35
8,127.35
8,127.35
Ordinary Shares Number
8,127.35
8,127.35
8,127.35
12/31/2021 - 11/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CUE Cue Biopharma, Inc.
1.3800
-7.38%
SEPN Septerna, Inc.
16.82
-8.97%
RYTM Rhythm Pharmaceuticals, Inc.
57.74
-0.07%
UPB Upstream Bio, Inc.
9.84
-5.29%
ACOG Alpha Cognition Inc. Common Stock
6.25
-6.43%
MBX MBX Biosciences, Inc.
10.74
-0.09%
FENC Fennec Pharmaceuticals Inc.
6.50
+4.33%
COEP Coeptis Therapeutics Holdings, Inc.
13.49
+13.29%
RAPP Rapport Therapeutics, Inc.
13.58
-2.30%
IBO Impact BioMedical Inc.
1.9999
+13.05%